Nagoya University Researchers Develop Highly Accurate MicroRNA Urine Test That Identifies Brain Cancer in Patients with Tumors

Mar 23, 2022 | Digital Pathology, International Laboratory News, Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Pathology, Laboratory Testing, Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing, Precision Medicine

MicroRNAs in urine could prove to be promising biomarkers in clinical laboratory tests designed to diagnose brain tumors regardless of the tumor’s size or malignancy, paving the way for early detection and treatment Researchers at Nagoya University in Japan have developed a liquid biopsy test for brain cancer screening that, they claim, can identify brain tumors in patients with 100% sensitivity and 97% specificity, regardless of the tumor’s size or malignancy. Pathologists will be interested...

MIT’s New Nanoparticle-based Technology Detects Cancer by Using a Multimodal Combination of Urine Tests and Medical Imaging

Aug 9, 2021 | Digital Pathology, Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Pathology, Precision Medicine

Use of such precision diagnostics offer ‘early detection, localization, and the opportunity to monitor response to therapy,’ say the MIT scientists Oncologists and medical laboratory scientists know that most clinical laboratory tests currently used to diagnose cancer are either based on medical imaging technologies—such as CT scans and mammography—or on molecular diagnostics that detect cancer molecules in the body’s urine or blood. Now, in a study being conducted at the Massachusetts...
;